Offer - Urjas Oil for just ₹ 1 X
Olsavas M is a prescription drug, available for use as Tablet. Other than this, Olsavas M has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Olsavas M depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
The most common side effects of Olsavas M are Upper respiratory tract infection, Slow heart rate (pulse). Besides the aforementioned side effects, there are other adverse effects of Olsavas M as well, which are listed below. Normally, these side effects of Olsavas M are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Olsavas M is Severe for pregnant women and Mild for women who are breastfeeding. Further, the section on Olsavas M related warnings talks about Olsavas M's effects on the liver, heart and kidney.
Olsavas M is contraindicated in people with pre-existing medical conditions like Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Bradycardia (Slow Heart Rate) as it can result in adverse effects. Other contraindications of Olsavas M have been discussed in the sections ahead.
Additionally, Olsavas M may also adversely react with other medicines. Refer to the list below for further details.
You should also be aware that Olsavas M is not safe while driving, and is not addiction.
Olsavas M is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Olsavas M safe for pregnant women?
Pregnant women may get severe side effects after taking Olsavas M. If you are pregnant, do not take Olsavas M without a doctor's advice.
Is the use of Olsavas M safe during breastfeeding?
Side effects of Olsavas M on breastfeeding women are very mild.
What is the effect of Olsavas M on the Kidneys?
Olsavas M does not damage the kidneys.
What is the effect of Olsavas M on the Liver?
Olsavas M has very mild side effects on the liver.
What is the effect of Olsavas M on the Heart?
Olsavas M may have mild side effects on the heart. Most people will never see any effect on the heart.
Olsavas M should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Olsavas M unless your doctor advises you to do so -
Is this Olsavas M habit forming or addictive?
Forming a habit of Olsavas M has not been reported.
Interaction between Food and Olsavas M
Eating certain foods may increase the time it takes Olsavas M to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Olsavas M
Consumption of alcohol and Olsavas M together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850